Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer
Ropivacaine, a local anesthetic, exhibits anti-tumor effects in various cancer types. However, its specific functions and the molecular mechanisms involved in breast cancer cell stemness remain elusive.
Source: Journal of Experimental and Clinical Cancer Research - Category: Cancer & Oncology Authors: Lin Ding, Hui Jiang, Qiangwei Li, Qiushuang Li, Tian-Tian Zhang, Limeng Shang, Bin Xie, Yaling Zhu, Keshuo Ding, Xuanming Shi, Tao Zhu and Yong Zhu Tags: Research Source Type: research